filmov
tv
Webinar: Is Pre-treatment Active Surveillance for Prostate Cancer Safe? 04/29/24
Показать описание
When world famous physician-scientist, leader of The Human Genome Project and former NIH Chief, Dr. Francis Collins, suddenly needs treatment for his prostate cancer that has accelerated from indolent to aggressive faster than a Formula 1 racer, many patients and medical professionals ask - whats up? The NIH/NCI is considered one of the best medical institutions in the world.
Did their active surveillance (AS) protocol fail or was Dr. Collins an anomaly?
Do patients need to worry?
... and is 'cure' really a possibility for Dr. Collins?
At short notice, AnCan Foundation, ASPI and The Active Surveillor have gathered together two world-renown urologists who curate their own AS cohorts. Drs. Peter Carroll and Laurie Klotz will discuss their views on the safety of pre-treatment AS for prostate cancer. Howard Wolinsky will moderate the discussion. AnCan's own AS Support Group Moderators will be speaking after the presentation sharing their own thoughts
AnCan is grateful to the following sponsors for making this webinar possible: Bayer, Novartis, Johnson & Johnson, Myriad Genetics, Telix & Blue Earth Diagnostics.
Did their active surveillance (AS) protocol fail or was Dr. Collins an anomaly?
Do patients need to worry?
... and is 'cure' really a possibility for Dr. Collins?
At short notice, AnCan Foundation, ASPI and The Active Surveillor have gathered together two world-renown urologists who curate their own AS cohorts. Drs. Peter Carroll and Laurie Klotz will discuss their views on the safety of pre-treatment AS for prostate cancer. Howard Wolinsky will moderate the discussion. AnCan's own AS Support Group Moderators will be speaking after the presentation sharing their own thoughts
AnCan is grateful to the following sponsors for making this webinar possible: Bayer, Novartis, Johnson & Johnson, Myriad Genetics, Telix & Blue Earth Diagnostics.
1:31:52
Webinar: Is Pre-treatment Active Surveillance for Prostate Cancer Safe? 04/29/24
1:11:19
Webinar: An introduction to active surveillance
1:55:20
Active Surveillance Support Group Webinar: How Do You Know When to Enter AS and When to Leave
1:37:15
FREE WEBINAR | TULSA PRO and ACTIVE SURVEILLANCE | Laurence Klotz, MD & Mark Moyad, MD, MPH
0:54:39
Urowebinar: MRI and active surveillance in prostate cancer
1:03:24
Europa Uomo active surveillance webinar 5
0:45:27
5.27.2020 Urology COViD Didactics - Active Surveillance for Early Stage Prostate Cancer
0:50:38
The Impact of a Genomic Assay on Urologist Treatment Preference in Active Surveillance-Eligible Men
1:22:05
Fuel to Win: Nutrition Webinar by Sporting Ethos & Tirang Sports
0:47:03
What's New in Active Surveillance for Prostate Cancer
0:49:07
Active Surveillance with Dr. Laurence Klotz - ZERO Prostate Cancer Summit 2022
0:58:16
Prostate Cancer: Active surveillance as a treatment option?
0:20:50
Active Surveillance 2021 - From Bench to Bedside
0:51:15
2017 Prostate Special Study Webinar #1
0:24:04
Active Surveillance or Focal Therapy as Primary Management
0:20:23
Active Surveillance Criteria and Follow-up Protocol
1:09:54
Active Surveillance & Beyond Webinar - The Value of mpMRI in Monitoring with Dr. Westphalen - Pa...
0:17:53
How to Choose Prostate Cancer Treatment: Patient-Focused Webinar
0:20:44
Active Surveillance 2021 (Part 3) - Patient Selection, Monitoring, and Innocuous Interventions
1:07:03
Next Steps in Personalized Medicine- Using Genomics and Imaging
0:08:21
Active Surveillance: A New Paradigm in Patient Safety
1:20:44
Active Surveillance and Beyond - Continuing the Conversation on mpMRI with Dr. Antonio Westphalen
0:31:38
2017 Prostate Special Study Webinar #16
0:02:43
Active Surveillance vs. Watchful Waiting
Комментарии